Quantcast

Latest Beta cell Stories

2010-09-22 10:59:00

GORDONSVILLE, Va., Sept. 22 /PRNewswire/ -- The cellular services company Beta-Pro LLC, announced today that it donated more than 300,000 human pancreatic islet cells to nationally renowned diabetes researcher Raghavendra G. Mirmira, M.D., Ph.D., the Eli Lilly & Co.

9f127d86c913a03ec015cc7b8287927d1
2010-09-13 06:09:43

Scientists say that shedding light on how a malfunctioning protein helps trigger type 2 diabetes could eventually help offer the chance to stop the damage.

2010-07-28 14:34:57

With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes.

2010-07-21 10:29:00

NEENAH, Wis., July 21 /PRNewswire/ -- A scientific journal, Phytotherapy Research (May 17, 2010), has reported findings from research teams at King's College London and at Burdwan Medical College, J. B. Ayurved College and Calcutta University (West Bengal).

2010-07-13 15:21:41

Disruption of two genes that control circadian rhythms can lead to diabetes.

2010-07-02 19:59:04

The muscle weakness and coordination problems sometimes seen in patients with neonatal diabetes – a rare, inherited form of diabetes – are caused by problems in the brain rather than the muscles

2010-06-29 02:28:21

The cause of diabetes during pregnancy is directly controlled by serotonin, a chemical produced by the body and normally known as a neurotransmitter, and is influenced by the amount of protein in the mother's diet early in pregnancy.

2010-06-28 06:00:00

CAMBRIDGE, Mass., June 28 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes.

2010-06-28 06:00:00

ORLANDO, Fla., June 28 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today presented an analysis of baseline data from the Phase 3 DEFEND-1 clinical trial of otelixizumab in patients with autoimmune new onset type 1 diabetes.

b251137d98962103f3099c8c3622d2cd1
2010-06-28 06:30:00

An international team of scientists said they have found 12 new gene links that offer important clues to how the chronic disease diabetes works.


Latest Beta cell Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related